What is CAGR? What does CAGR table indicate for Transchem Ltd?

Compounded average growth rate (CAGR) measures the average annual growth rate compounded year-on-year over a period of time.

Transchem Ltd Stock Analysis

Q: Is Transchem Ltd a good quality company?

MoneyWorks4Me analysed the past 10-year performance of Transchem Ltd and arrived at the following conclusion.

Q: Is the current market price of Transchem Ltd a good price to buy it?

The 5-year analysis of Transchem Ltd's performance infers.

Small Cap

Evaluated by 82 users | BSE: 500422 | NSE: TRANSCHEM |
Agriculture

Transchem limited is a professionally managed, public limited company, the API manufacturing operations were started in 1993. The company is reputed as quality conscious manufacturer and exporter of specialized high quality API's and pharmaceutical intermediates.The company is the largest...

10 Year X-Ray

Standalone basis Standalone basis P Consolidated basis

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

What is a Financial Track Record? How to read this chart in order to understand the data present here?

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20
Return on Capital Employed	-3.37%	-1.7%	-1.29%	-1.64%	0.31%	-2.92%	-3.35%	-4.92%	0.44%	1.03%

Growth Parameters	Growth Parameters Colour Code Guide

Net Sales (Rs. Cr.)	0	0	0	0	0	0	0	0	0	0
Y-o-Y Gr. Rt.	-	NA	NA	NA	NA	NA	NA	NA	NA	NA
Adjusted EPS (Rs.)	-1.34	-0.74	-0.59	-0.55	0.1	-0.91	-1.05	-1.5	0.14	0.31
Y-o-Y Gr. Rt.	-	NA	NA	NA	NA	-1010%	NA	NA	NA	121.4%
Book Value per Share (Rs.)	35.69	32.97	31.89	31.23	31.33	31.37	31.04	30.07	31.03	30.04
Adjusted Net Profit	-1.6	-0.9	-0.7	-0.7	0.1	-1.1	-1.3	-1.8	0.2	0.4
Net Op. Cash Flow (Rs. Cr.)	-5.5	1.2	1.8	0.6	0.9	1.1	0.6	-19.8	10.3	-0.6
Debt to Cash Flow from Ops	-0.55	2.57	0.9	0	0	0	0	0	0	0

Difference between Standalone Basis and Consolidated basis? Which method is preferred for Transchem Ltd. ?

Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.

Transchem Ltd. should be analysed on a Standalone basis

CAGR CAGR Colour Code Guide

	9 yrs	5 yrs	3 yrs	1 yr
Net Sales	NA	NA	NA	NA
Adjusted EPS	NA	25.4%	NA	121.4%
Book Value per Share	-1.9	-0.8	-1.1	-3.2
Share Price	0.5%	1.7%	-19.1%	-3.7%

Key Financial Parameter	Performance Ratio Colour Code Guide

	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20
Return on Equity (%)	-3.63	-2.15	-1.82	-1.75	0.31	-2.92	-3.35	-4.92	0.44	1.03
Operating Profit Margin (%)	0	0	0	0	0	0	0	0	0	0
Net Profit Margin (%)	0	0	0	0	0	0	0	0	0	0
Debt to Equity	0.07	0.07	0.04	0	0	0	0	0	0	0
Working Capital Days	0	0	0	0	0	0	0	0	0	0
Cash Conversion Cycle	0	0	0	0	0	0	0	0	0	0

Management X-Ray

Shareholding Pattern

Entity	Percentage Holding
Promoters	39.29%
Institutions	0.03%
Non-Institutions	60.68%

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

FAQs

1. Is Transchem Ltd a good quality company?

Data is not available for this company.

2. Is current market price of Transchem Ltd a good price to buy it?

The 5-year analysis of Transchem Ltd's performance infers:

Transchem Ltd earnings have grown by 25.4%, whereas share price has appreciated 1.7% CAGR over the past five years, indicating the company's share price is likely undervalued. However, for specific investment actions please connect with your investment advisor.

3. What is Transchem Ltd share price return in the past 10 years ?

We analysed the performance of Transchem Ltd share prices over the last 10 years. Here is what we found out:

Transchem Ltd share price has appreciated 2.3% annually over the past ten years.

About Company

The company is the largest producer of widest range of Anathematic API's (Anti-Parasitic) in the world, manufactured under one roof in WHO GMP accredited facility. It also offers specialized range of human use APIâ€™s.

The

The company is having four state of the art GMP approved facilities at multiple locations in India, with total production capacity of 500 MT per annum.

The company is one of the largest suppliers of Albendazole, Clorsulon, Diminazene Diaceturate, Toldimfos Sodium, Oxfendazole, Fenbendazole, Flubendazole, Mebendazole, Nitroxynil, Ramipril from India and can meet all the requiered technical and quality aspects of esteemed organizations and is now focusing on Anti-Hypertensive and Anti-Diabetic range of products.

Products and services offered by the company:

Services: